# 2026-20065: FDA Wants Nominations for Health Advisory Panels

2026-20065, Request for Nominations for Individuals and Consumer Organizations for Advisory Committees, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-10-01, effective 2026-11-16 (as of 2026-10-08).

- Canonical: https://policyrisk.com/federal-register/2026-20065
- As of: 2026-10-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-20065
- Title: Request for Nominations for Individuals and Consumer Organizations for Advisory Committees
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 62522
- Published: 2026-10-01
- Effective: 2026-11-16
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-10-08

## In one line

FDA Wants Nominations for Health Advisory Panels

## Summary

The FDA is looking for people and consumer groups to join its advisory committees and share their views on important health topics. If you or your group want to help pick voting or nonvoting members, or if you want to be nominated yourself, act by November 16, 2026. This is a great chance to have a say in decisions that affect everyone’s health, with no cost to apply!

## Abstract

The Food and Drug Administration (FDA or Agency) is requesting that any consumer organizations interested in participating in the selection of voting and/or nonvoting consumer representatives to serve on its advisory committees or panels notify FDA in writing. FDA is also requesting nominations for voting and/or nonvoting consumer representatives to serve on advisory committees and/or panels for which vacancies currently exist or are expected to occur in the near future. Nominees recommended to serve as a voting or nonvoting consumer representative may be self-nominated or may be nominated by a consumer organization. FDA seeks to include the views of individuals on its advisory committees selected without regard to race, color, national origin, religion, age, or sex.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-20065 on federalregister.gov](https://www.federalregister.gov/documents/2026/10/01/2026-20065/request-for-nominations-for-individuals-and-consumer-organizations-for-advisory-committees)
- [2026-20065 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-10-01/pdf/2026-20065.pdf)

## Related
- [Previous: 2026-20063, Request for Nominations for Voting Members of Food and Drug Administration Advi…](https://policyrisk.com/federal-register/2026-20063)
- [Next: 2026-20068, Availability of Two Draft Toxicological Profiles](https://policyrisk.com/federal-register/2026-20068)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-20065 (as of 2026-10-08).
